527
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis

ORCID Icon, , , , , & show all
Pages 520-527 | Received 04 May 2017, Accepted 27 Jun 2017, Published online: 12 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ksenia Brusilovskaya, Benedikt Simbrunner, Silvia Lee, Beate Eichelberger, David Bauer, Kerstin Zinober, Philipp Schwabl, Mattias Mandorfer, Simon Panzer, Thomas Reiberger & Thomas Gremmel. (2022) Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. Platelets 33:6, pages 879-886.
Read now
Lin Xiang Liu, Yue Zhang, Yuan Nie & Xuan Zhu. (2020) Assessing the Prediction Effect of Various Prognosis Model for 28-Day Mortality in Acute-on-Chronic Liver Failure Patients. Risk Management and Healthcare Policy 13, pages 3155-3163.
Read now
Hui Zhang, Shaoying Zhang, Jian Zhang, Rui Zhou, Yongzhan Nie, Song Ren, Jun Li, Keping Feng, Fanpu Ji, Guangyao Kong & Zongfang Li. (2020) Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. Platelets 31:8, pages 1019-1027.
Read now
Andrew L. Frelinger$suffix/text()$suffix/text(). (2018) Using flow cytometry to monitor glycoprotein IIb-IIIa activation. Platelets 29:7, pages 670-676.
Read now

Articles from other publishers (27)

Ksenia Brusilovskaya, Benedikt Silvester Hofer, Benedikt Simbrunner, Beate Eichelberger, Silvia Lee, David J. M. Bauer, Mattias Mandorfer, Philipp Schwabl, Simon Panzer, Thomas Reiberger & Thomas Gremmel. (2023) Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension—A Prospective Study. Thrombosis and Haemostasis 123:12, pages 1140-1150.
Crossref
Navya Malladi, Md Jahangir Alam, Subir K. Maulik & Sanjay K. Banerjee. (2023) The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 169, pages 106766.
Crossref
Xueshi Zhou, Xinyue Chen, Hejuan Du, Yangqun Ye, Youhan Miu, Tingting Su, Xiaoye Guo, Sen Wang, Yuanwang Qiu, Jun Wang & Weifeng Zhao. (2023) Antithrombin III activity is associated with prognosis, infection, and inflammation in patients with hepatitis B virus-related acute-on-chronic liver failure. European Journal of Gastroenterology & Hepatology 35:8, pages 914-920.
Crossref
Asala Nassar, Jan Patrick Huber, Daniela Stallmann, Diana Sharipova, Muataz Ali Hamad, Michael Schultheiss, Robert Thimme, Daniel Duerschmied, Rüdiger Eberhard Scharf, Dominik Bettinger & Krystin Krauel. (2023) Decreased Platelet Aggregation in Patients with Decompensated Liver Cirrhosis and TIPS Implantation. Biomedicines 11:7, pages 2057.
Crossref
Marie‐Astrid van Dievoet, Xavier Stephenne, Madeleine Rousseaux, Ton Lisman, Cedric Hermans & Véronique Deneys. (2023) The use of prothrombin complex concentrate in chronic liver disease: A review of the literature. Transfusion Medicine 33:3, pages 205-212.
Crossref
Badi Rawashdeh, Joohyun Kim & Johnny Hong. (2022) Spontaneous Retroperitoneal Hematoma: A Deadly Complication for Patients Awaiting Liver Transplant. Cureus.
Crossref
Julien Bissonnette, Alix Riescher‐Tuczkiewicz, Elia Gigante, Carole Bourdin, Larbi Boudaoud, Heithem Soliman, François Durand, Maxime Ronot, Dominique Valla, Valérie Vilgrain, Emmanuelle de Raucourt & Pierre‐Emmanuel Rautou. (2022) Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures. Journal of Thrombosis and Haemostasis 20:12, pages 2786-2796.
Crossref
Sheng-Hung Chen, Shih-Chang Tsai & Hsiu-Chen Lu. (2022) Platelets as a Gauge of Liver Disease Kinetics?. International Journal of Molecular Sciences 23:19, pages 11460.
Crossref
Bente P. van den Boom & Ton Lisman. (2022) Pathophysiology and management of bleeding and thrombosis in patients with liver disease. International Journal of Laboratory Hematology 44:S1, pages 79-88.
Crossref
Uta Schilling, Chih‐Hsuan Hsin, Stephane Delahaye, Andreas Krause, Hauke Wuelfrath, Atef Halabi & Jasper Dingemanse. (2022) Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel . Clinical and Translational Science 15:8, pages 1906-1915.
Crossref
Emil B. Riahi, Kasper Adelborg, Lars Pedersen, Søren R. Kristensen, Anette T. Hansen & Henrik T. Sørensen. (2022) Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study. Research and Practice in Thrombosis and Haemostasis 6:2, pages e12668.
Crossref
Chih-Lung Shen & Yi-Feng Wu. (2022) Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia. Tzu Chi Medical Journal 34:4, pages 381.
Crossref
Xiang Xu, Chen Li, Jing Chen, Xiaoyan Liu, Haibin Su, Jingjing Tong & Jinhua Hu. (2021) Relationship Between Platelet to White Blood Cell Ratio and 30-Day Prognosis of Patients with Acute-on-Chronic Liver Failure. Hepatitis Monthly 21:9.
Crossref
Hannah Stowe McMurry, Janice Jou & Joseph Shatzel. (2021) The hemostatic and thrombotic complications of liver disease. European Journal of Haematology 107:4, pages 383-392.
Crossref
Peng-Xin Ge, Li-Ping Jiang, Ting Tai, Ting Zhu, Jin-Zi Ji, Yi-Fei Li, Qiong-Yu Mi & Hong-Guang Xie. (2021) Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice. Life Sciences 279, pages 119268.
Crossref
Tapasyapreeti Mukhopadhyay, Arulselvi Subramanian, Venencia Albert, Anand Kumar, Shyam Prakash & Hara Prasad Pati. (2020) Platelet Function Analysis by Flowcytometry in Thrombocytopenic Trauma Patients. Indian Journal of Hematology and Blood Transfusion 37:3, pages 398-403.
Crossref
Yvonne Brennan, Marie Levade & Christopher M. Ward. (2020) Acquired platelet function disorders. Thrombosis Research 196, pages 561-568.
Crossref
Neta Gotlieb, Naama Schwartz, Shira Zelber-Sagi, Gabriel Chodick, Varda Shalev & Oren Shibolet. (2020) Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World Journal of Gastroenterology 26:38, pages 5849-5862.
Crossref
Gang Liu, Alan W. Baird, Marie J. Parsons, Kening Fan, David A. Skerrett‐Byrne, Prema M. Nair, Samwel Makanyengo, Jinbiao Chen, Rachel Neal, Bridie J. Goggins, Hock Tay, Andrea Mathe, Wai S. Soh, Kyra Minahan, Phil M. Hansbro, Brett Nixon, Geoffrey W. McCaughan, Gerald Holtmann, Sean P. Colgan & Simon Keely. (2020) Platelet activating factor receptor acts to limit colitis‐induced liver inflammation. The FASEB Journal 34:6, pages 7718-7732.
Crossref
Maxime G. Zermatten, Montserrat Fraga, Darius Moradpour, Debora Bertaggia Calderara, Alessandro Aliotta, Guido Stirnimann, Andrea De Gottardi & Lorenzo Alberio. (2020) Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 71:6, pages 2135-2148.
Crossref
Marie-Astrid van Dievoet, Stéphane Eeckhoudt & Xavier Stephenne. (2020) Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?. International Journal of Molecular Sciences 21:9, pages 3294.
Crossref
Christian Kring, Lars M. Rasmussen, Jes S. Lindholt, Axel C. P. Diederichsen & Pernille J. Vinholt. (2019) Platelet aggregation is not altered among men with diabetes mellitus. Acta Diabetologica 57:4, pages 389-399.
Crossref
N. R. Matkovska. (2020) CHANGES IN THE HAEMOSTASIS SYSTEM UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS IN COMBINATION WITH OBESITY USING ADEMETHIONINE, ARGININE GLUTAMATE AND ROSUVASTATIN. Likarska sprava:1-2, pages 42-49.
Crossref
Pierluigi Ramadori, Thomas Klag, Nisar Peter Malek & Mathias Heikenwalder. (2019) Platelets in chronic liver disease, from bench to bedside. JHEP Reports 1:6, pages 448-459.
Crossref
Lasse L. Langholm, Tina Manon-Jensen, Morten A. Karsdal, Flemming Bendtsen, Diana J. Leeming & Søren Møller. (2019) Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis. European Journal of Gastroenterology & Hepatology 31:8, pages 1040-1048.
Crossref
Nataliia Matkovska. (2019) CHANGES IN THE HAEMOSTASIS SYSTEM OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE. World Science 3:6(46), pages 22-25.
Crossref
Liz Ryan. (2019) Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate. EMJ Hepatology, pages 30-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.